The pathophysiology of hepatocellular carcinoma (HCC) is prevalently related to genomic instability. However, research on the association of extensive genome instability lncRNA (GILnc) with the progno

NIAID Data Ecosystem40

Supplementary Material for: Duration of Stable Disease Is Associated with Overall Survival in Patients with Advanced Hepatocellular Carcinoma Treated with Sorafenib

肝细胞癌预后

索拉非尼疗效评估

Background: Sorafenib is a molecular-targeting agent showing improved overall survival (OS) for advanced hepatocellular carcinoma (HCC). Although tumor dormancy, characterized by stable tumor status o

NIAID Data Ecosystem20

Supplementary Material for: Analysis of Post-Progression Survival in Patients with Unresectable Hepatocellular Carcinoma Treated with Lenvatinib

肝细胞癌预后

靶向治疗疗效评估

Background: Although a strong antitumor effect of lenvatinib (LEN) has been noted for patients with unresectable hepatocellular carcinoma (HCC), there are still no reports on the prognosis for patient

NIAID Data Ecosystem60

Table5_Clinical neutrophil-associated genes as reliable predictors of hepatocellular carcinoma.XLSX

肝细胞癌预后

中性粒细胞相关基因

Background: Growing evidence suggests that infiltrating neutrophils are key players in hepatocellular carcinoma (HCC) tumor progression. However, a comprehensive analysis of the biological roles of ne

NIAID Data Ecosystem30

A Methylation-Based Signature Predicts Survival In Hepatocellular Carcinoma Patient

资源简介：

相关数据集